Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

Applied Therapeutics Inc

CUSIP: 03828A951 | 5 institutional holders

Quarters

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024

Compare Detailed Historical Funds Options Short Interest 13D/13G Peers Targeting Trading Summary Profile